Key Insights

Highlights

Success Rate

67% trial completion

Treatment Research

17 treatments under study, led by Netazepide

Research Leaders

20 sponsors active, led by Beijing University of Chinese Medicine

Related Conditions

Often studied with 11 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

7.7%

1 terminated out of 13 trials

Success Rate

66.7%

-19.9% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results67% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (3)
Early Phase 1 (1)
Phase 2 (3)

Trial Status

Unknown6
Completed2
Active Not Recruiting2
Not Yet Recruiting2
Terminated1

Trial Success Rate

66.7%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT02782949Phase 2Active Not RecruitingPrimary

Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia

NCT07319338Not Yet RecruitingPrimary

Objective Vascular Biomarkers as Triage for Depression in Chronic Atrophic Gastritis

NCT07152860Not ApplicableNot Yet RecruitingPrimary

Evaluation of the Efficacy of Electroacupuncture in the Treatment of Chronic Atrophic Gastritis

NCT06489132UnknownPrimary

Objective Study on Tongue Diagnosis of Chronic Atrophic Gastritis

NCT05808010Not ApplicableUnknownPrimary

Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic Gastritis

NCT06267703Active Not RecruitingPrimary

Multi-omics Analyses on Etiology and Early Detection of Stomach Cancer Precursor Lesions

NCT06085677Unknown

The Gastric HormonE BioMarkers of Preneoplastic Lesions Study

NCT05388890UnknownPrimary

Treatment of Atrophic Gastritis After HP Eradication With Modified Liujunzi Decoction Based on Syndrome Differentiation

NCT05493124Early Phase 1UnknownPrimary

Clinical Study of Manpixiao in the Treatment of Chronic Atrophic Gastritis

NCT02955134Not ApplicableCompletedPrimary

The Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis

NCT01339169Phase 2CompletedPrimary

YF476 and Type I Gastric Carcinoids

NCT03597672Unknown

Early Detection and Screening Strategy of Gatric Cancer in Sichuan Province-A Prospective Cohort Study (WCH-GC-SIGES-01)

NCT01444014Phase 2TerminatedPrimary

YF476 and Type I Gastric Carcinoids (Norway)

Showing all 13 trials

Research Network

Common Treatments

  • Netazepide2
  • Mld1
  • Laboratory Biomarker Analysis1
  • Talcid1
  • Weifuchunhydrotalcitelglutamine And Sodium Gualenate Granules1

Active Sponsors

  • Beijing University of Chinese Medicine2
  • Trio Medicines Ltd.2
  • Peking University First Hospital2
  • Beijing Anzhen Hospital1
  • Xin-Zu Chen1

Top Investigators

Related Conditions

  • Type I Gastric Carcinoids2
  • Stomach Neoplasm1
  • H Pylori Infection1
  • Neoplasm Stomach1
  • Intestinal Metaplasia1

Activity Timeline